3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pain
3
Neoplasms
3
Lymphoma, Follicular
2
Breast Neoplasms
2
Trigger Finger Disorder
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pituitary Neoplasms
1
Patient Satisfaction
1
Nose Neoplasms
1
Mucositis
1
Menorrhagia
1
Mastocytosis, Systemic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Hairy Cell
1
Leiomyoma
1
Hodgkin Disease
1
Hemorrhage
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Ganglion Cysts
1
Esthesioneuroblastoma, Olfactory
1
Dupuytren Contracture
1
De Quervain Disease
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Carpal Tunnel Syndrome
1
Cachexia
1
Burkitt Lymphoma
1
Breast Diseases
1
Interventions
Ropivacaine
6
Anesthesia, General
6
Analgesics, Opioid
6
Morphine
5
Acetaminophen
5
Saline Solution
4
Lidocaine
4
Ketamine
4
Fentanyl
4
Sodium Chloride
3
Dexmedetomidine
3
Bupivacaine
3
Anesthetics, Local
3
Anesthesia, Local
3
Acupuncture Therapy
3
trimebutine 3-thiocarbamoylbenzenesulfonate
2
parecoxib
2
Transcutaneous Electric Nerve Stimulation
2
Tramadol
2
Therapeutics
2
Tea
2
Surveys and Questionnaires
2
Propofol
2
Oxycodone
2
Magnesium Sulfate
2
Levobupivacaine
2
Control Groups
2
ramosetron
1
acetaminophen, codeine drug combination
1
Varenicline
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Agnosia
×
Ibuprofen
×
Clear all
NCT00299039
2009-02-02
T3AI
Nova Scotia Health Authority
Phase 3
Completed
150 enrolled